tiprankstipranks
Trending News
More News >
Myriad Genetics (MYGN)
NASDAQ:MYGN
US Market

Myriad Genetics (MYGN) Income Statement

Compare
420 Followers

Myriad Genetics Income Statement

Last quarter (Q3 2025), Myriad Genetics's total revenue was $205.70M, a decrease of -3.56% from the same quarter last year. In Q3, Myriad Genetics's net income was $-27.40M. See Myriad Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 837.60M$ 753.20M$ 678.40M$ 690.60M$ 557.00M
Gross Profit
$ 585.40M$ 517.00M$ 476.40M$ 493.00M$ 378.80M
Operating Expenses
$ 708.90M$ 774.40M$ 617.00M$ 683.50M$ 653.30M
Depreciation and Amortization
$ 61.20M$ 61.90M$ 52.70M$ 62.80M$ 71.40M
EBITDA
$ -59.50M$ -197.40M$ -84.70M$ 12.30M$ -123.40M
Operating Income
$ -123.50M$ -257.40M$ -140.60M$ -190.50M$ -194.80M
Other Income/Expenses
$ 0.00$ -4.80M$ 0.00$ 133.40M$ -88.90M
Pretax Income
$ -123.50M$ -262.20M$ -140.60M$ -57.10M$ -283.70M
Net Income
$ -127.30M$ -263.30M$ -112.00M$ -27.20M$ -223.70M
Per Share Metrics
Basic EPS
$ -1.41$ -3.18$ -1.39$ -0.35$ -2.99
Diluted EPS
$ -1.41$ -3.18$ -1.39$ -0.35$ -2.99
Weighted Average Shares Outstanding
90.60M 82.80M 80.58M 77.71M 74.70M
Weighted Average Shares Outstanding (Diluted)
90.60M 82.80M 80.60M 78.00M 74.78M
Currency in USD

Myriad Genetics Earnings and Revenue History